{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:08:03Z","timestamp":1791281283180,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ajog.2003.09.028","type":"journal-article","created":{"date-parts":[[2004,3,23]],"date-time":"2004-03-23T18:29:08Z","timestamp":1080066548000},"page":"721-729","source":"Crossref","is-referenced-by-count":54,"title":["An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years"],"prefix":"10.1016","volume":"190","author":[{"suffix":"Jr.","given":"Joseph R","family":"Biggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.Christopher","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery S.A","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2003.09.028_BIB1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.bmb.a011733","article-title":"Prenatal screening for chromosome abnormalities","volume":"54","author":"Chitty","year":"1998","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ajog.2003.09.028_BIB2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02984413","article-title":"The relative effects of paternal and maternal age in mongolism","volume":"27","author":"Penrose","year":"1933","journal-title":"J Genetics"},{"key":"10.1016\/j.ajog.2003.09.028_BIB3","first-page":"197","article-title":"Prenatal diagnosis of Down's syndrome","volume":"2","author":"Valenti","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2003.09.028_BIB4","first-page":"72","article-title":"A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol","volume":"81","author":"Cheng","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0002-9378(95)90007-1","article-title":"The advantages of using triple-marker screening for chromosomal abnormalities","volume":"172","author":"Kellner","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB6","first-page":"63","article-title":"Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age","volume":"77","author":"MacDonald","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1399-0004.1990.tb03388.x","article-title":"Maternal serum markers in screening for Down syndrome","volume":"37","author":"Norgaard-Pedersen","year":"1990","journal-title":"Clin Genet"},{"key":"10.1016\/j.ajog.2003.09.028_BIB8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM199208273270902","article-title":"Prenatal screening for Down's syndrome with use of maternal serum markers","volume":"327","author":"Haddow","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB9","first-page":"353","article-title":"Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study","volume":"80","author":"Phillips","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","article-title":"Dimeric inhibin A as a marker for Down's syndrome in early pregnancy","volume":"334","author":"Aitken","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F","article-title":"Prenatal screening for Down's syndrome using inhibin-A as a serum marker","volume":"16","author":"Wald","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9378(97)70001-2","article-title":"\u03b1-fetoprotein, free \u03b2-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome","volume":"177","author":"Wenstrom","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0002-9378(97)70002-4","article-title":"Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies","volume":"177","author":"Wenstrom","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-0528.1996.tb09765.x","article-title":"Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy","volume":"103","author":"Wald","year":"1996","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2003.09.028_BIB15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/(SICI)1097-0223(199906)19:6<505::AID-PD572>3.0.CO;2-6","article-title":"Appropriate biochemical parameters in first-trimester screening for Down syndrome","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0223(199901)19:1<8::AID-PD460>3.0.CO;2-1","article-title":"First-trimester biochemical markers for Down syndrome","volume":"19","author":"Casals","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM199804023381404","article-title":"Screening of maternal serum for fetal Down's syndrome in the first trimester","volume":"338","author":"Haddow","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.1997.10060381.x","article-title":"First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency","volume":"10","author":"Orlandi","year":"1997","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0705.1999.13040231.x","article-title":"A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free \u03b2-human chorionic gonadotropin and pregnancy associated plasma protein-A","volume":"13","author":"Spencer","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A","article-title":"Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency","volume":"19","author":"deGraaf","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-0528.1998.tb10239.x","article-title":"First trimester screening for Down's syndrome using maternal serum PAPP-A and free \u03b2-hCG in combination with fetal nuchal translucency thickness","volume":"105","author":"Biagiotti","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2003.09.028_BIB22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome","volume":"17","author":"Wald","year":"1997","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<360::AID-PD556>3.0.CO;2-U","article-title":"First-trimester screening for Down syndrome using nuchal translucency measurement with free \u03b2-hCG and PAPP-A between 10 and 13 weeks of pregnancy\u2014the combine test","volume":"19","author":"DeBiasio","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"For the first trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199908123410701","article-title":"Integrated screening for Down's syndrome based on tests performed during the first and second trimesters","volume":"341","author":"Wald","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1067\/mob.2000.104802","article-title":"First-trimester screening for aneuploidy: research or standard of care?","volume":"182","author":"Malone","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM199908123410709","article-title":"Prenatal screening for Down's syndrome\u2014a search for the family's values","volume":"341","author":"Copel","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB28","article-title":"Births: final data for 1998","volume":"Vol 48","author":"Ventura","year":"2000"},{"key":"10.1016\/j.ajog.2003.09.028_BIB29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/pd.1970140706","article-title":"Maternal age-specific risks for trisomies at 9-14 weeks' gestation","volume":"14","author":"Snijders","year":"1994","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1471-0528.1995.tb10845.x","article-title":"Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older","volume":"102","author":"Macintosh","year":"1995","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2003.09.028_BIB31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2010","article-title":"Antenatal screening for Down's syndrome","volume":"2","author":"Wald","year":"1998","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ajog.2003.09.028_BIB32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/bmj.305.6850.391","article-title":"Antenatal maternal serum screening for Down's syndrome: results of a demonstration project","volume":"305","author":"Wald","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2003.09.028_BIB33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-9378(93)90613-N","article-title":"A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol","volume":"169","author":"Burton","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/096914139400100109","article-title":"Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group","volume":"1","author":"Piggott","year":"1994","journal-title":"J Med Screen"},{"key":"10.1016\/j.ajog.2003.09.028_BIB35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/pd.1970140509","article-title":"Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme","volume":"14","author":"Goodburn","year":"1994","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pd.1970100802","article-title":"Determinants of parental decisions to abort for chromosome abnormalities","volume":"10","author":"Drugan","year":"1990","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.1320290320","article-title":"Parental decision following prenatal diagnosis of fetal chromosome abnormality","volume":"29","author":"Verp","year":"1988","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2003.09.028_BIB38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(86)91218-3","article-title":"Randomised controlled trial of genetic amniocentesis in 4606 low-risk women","volume":"1","author":"Tabor","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2003.09.028_BIB39","series-title":"Genetic disorders and the fetus: diagnosis, prevention, and treatment","article-title":"Maternal serum screening for neural tube and other defects","author":"Milunsky","year":"1998"},{"key":"10.1016\/j.ajog.2003.09.028_BIB40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJM199208273270903","article-title":"A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group","volume":"327","author":"Jackson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2003.09.028_BIB41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/pd.1970120508","article-title":"Canadian multicentre randomized clinical trial of chorion villus sampling and amniocentesis: final report","volume":"12","author":"Lippman","year":"1992","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2003.09.028_BIB42","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jama.285.8.1044","article-title":"Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis","volume":"285","author":"Smith-Bindman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2003.09.028_BIB43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0002-9378(98)70388-6","article-title":"An alternative for women initially declining genetic amniocentesis: individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers","volume":"179","author":"Bahado-Singh","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB44","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/0029-7844(96)00053-1","article-title":"The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21","volume":"87","author":"Vintzileos","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB45","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0002-9378(98)70134-6","article-title":"An economic evaluation of second-trimester genetic ultrasonography for prenatal detection of Down syndrome","volume":"179","author":"Vintzileos","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0029-7844(97)00227-5","article-title":"Choice of second-trimester genetic sonogram for detection of trisomy 21","volume":"90","author":"Vintzileos","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9378(95)90008-X","article-title":"Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography","volume":"172","author":"Vintzileos","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1471-0528.1998.tb09352.x","article-title":"The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry","volume":"105","author":"Verdin","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2003.09.028_BIB49","series-title":"Physicians' Fee Reference 2003","author":"Wasserman","year":"2003"},{"key":"10.1016\/j.ajog.2003.09.028_BIB50","first-page":"694","article-title":"Economic costs of birth defects and cerebral palsy\u2014United States, 1992","volume":"44","author":"Waitzman","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2003.09.028_BIB51","series-title":"Bureau of Labor Statistics. Consumer price index\u2014medical care","year":"2002"},{"key":"10.1016\/j.ajog.2003.09.028_BIB52","article-title":"Chorion villus sampling versus amniocentesis for prenatal diagnosis","author":"Alfirevic","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2003.09.028_BIB53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0029-7844(99)00613-4","article-title":"Cost-benefit analysis of prenatal diagnosis of Down syndrome using the British or the American approach","volume":"95","author":"Vintzileos","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bmj.323.7310.423","article-title":"Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies","volume":"323","author":"Gilbert","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2003.09.028_BIB55","series-title":"First-trimester screening for fetal anomalies with nuchal translucency. ACOG Committee Opinion 223","author":"American College of Obstetricians and Gynecologists","year":"1999"},{"key":"10.1016\/j.ajog.2003.09.028_BIB56","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9378(96)80006-8","article-title":"Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results","volume":"175","author":"Bahado-Singh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2003.09.028_BIB57","first-page":"1","article-title":"Prenatal care in the United States, 1980-94","volume":"54","author":"Lewis","year":"1996","journal-title":"Vital Health Stat 21"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937803011542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937803011542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T19:26:02Z","timestamp":1585682762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937803011542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0002937803011542"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2003.09.028","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}